Guidant Ancure Adverse Event Reporting Is Focus Of DoJ/FDA Probe
This article was originally published in The Gray Sheet
Executive Summary
Guidant's disclosure of a criminal investigation by the Department of Justice and FDA related to the Ancure abdominal aortic aneurysm endovascular graft comes just one week after the firm highlighted Cook's Zenith AAA device as a key driver of the $3 bil. merger deal